Johnson and Johnson Merck Consumer Pharmaceuticals

Bookmark

Add to MyYahoo RSS

Johnson and Johnson Merck Consumer Pharmaceuticals News

News on Johnson and Johnson Merck Consumer Pharmaceuticals continually updated from thousands of sources around the net.

1 hr ago | Seeking Alpha

Earnings Preview: Johnson & Johnson Q2 2014

Johnson & Johnson is slated to report 2Q 2014 earnings before the opening bell on Tuesday, July 15th.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

3 hrs ago | The Washington Post

Spinversions Make Giants Candidates to Escape U.S. Tax: Real M&A

American conglomerates that want a piece of the tax-inversion deal bonanza may start turning to a new tactic.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, LOC-AID Technologies

8 hrs ago | Philadelphia Gay News

N.J.-based corp. marks third year of LGBT initiative

Five years ago, Johnson & Johnson started hosting Gay 101 "lunch and learns" to find out more about the LGBT community as a consumer group.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

14 hrs ago | BBC News

Botticelli drawing sells for A 1.3m

Created in the 1480s, the piece - titled Study for a Seated Joseph, his head resting on his right hand - was the first drawing by the artist to be sold for a century.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Wed Jul 09, 2014

The Motley Fool

Is Pharmacyclics the Next Celgene?

Revlimid notched label expansions for use in multiple myeloma in 2006 and mantle cell lymphoma in 2013.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Seeking Alpha

Has Johnson & Johnson Finally Met Its Match?

In the latest instalment of our Head-To-Head series, we pitch two companies from the health care sector, Johnson & Johnson and Covidien, against one another.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

GigaOM

White House pulls plug on controversial Patent Office nominee after tech sector backlash

The Obama Administration has backed away from an unpopular plan to name a Johnson & Johnson executive and patent reform opponent as head of the US Patent Office.

Comment?

Related Topix: Patent / Trademark Law, Law, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Seeking Alpha

What's Your (Dividend Growth) Number?: Part 4 - Creating And Surpassing Goals

Be it financial, career-related or personal, achieving a major goal is a rush. Let's not undersell how satisfying it is to reach the little milestones along the way, however, because hitting those targets can keep us focused on The Big One.

Comment?

Related Topix: Personal Finance, Retirement, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Chevron Corporation, Energy, Oil & Gas, General Mills, Food, Agriculture

Reuters

UPDATE 2-Sodexo cuts sales growth forecast due to contract delays

Sodexo, the world's second-biggest catering services company, cut it full-year sales growth forecast on Wednesday, warning its fourth quarter would be weaker than expected due to the delayed start-up of some large contracts.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Tue Jul 08, 2014

Safehaven

Will Dividend Stocks Save You In A Bear Market?

In recent years, many investors have been attracted to the "safety" and "wealth-building" appeal of dividend stocks.

Comment?

Related Topix: Financial Markets, Personal Finance, Retirement, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

WFAA-TV Dallas

Texas attorney general's office investigating pelvic mesh

The Texas Attorney General's Office has Johnson & Johnson and its subsidiary, Ethicon, in its sights for potential deceptive trade violations.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Texas, Aria Systems, VisionCare Ophthalmic Technologies, Startups

Montreal Gazette

Energizer Holdings to shut Montreal factory; 430 jobs gone

Just nine months after buying the east-end Johnson & Johnson factory, Energizer Holdings announced Tuesday it will shut down the facility beginning next summer.

Comment?

Related Topix: Energizer HLDGS, Electronics, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

VentureBeat

Kony Appoints Two Industry Luminaries to Complete Executive Team

Check out our press release hub , powered by Business Wire. It's a one stop shop for industry announcements to help you stay on top of the latest technology and investment trends.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, LOC-AID Technologies

Customer Interaction Solutions

Ortho-Clinical Diagnostics, Inc. Announces Executive Leadership...

Today Ortho-Clinical Diagnostics, Inc. unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group from Johnson & Johnson.

Comment?

Related Topix: Medicine, OrthoClinical Diagnostics, Medical Equipment, Healthcare Industry, Johnson & Johnson, Biotech, Johnson and Johnson

The Motley Fool

3 Reasons to Buy Medivation Inc.

The biotech industry has ballooned in terms of market value over the past two years.

Comment?

Related Topix: Startups, Medivation, Prostate Cancer, Health, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Breast Cancer

Mon Jul 07, 2014

The Motley Fool

The Dow Breaks Its Streak but Holds 17,000 as Johnson & Johnson and AT&T Rise

Yet even as nervous investors took profits after weighing the potential for future gains against the risk involved in the stock market, the Dow still managed to hang onto the 17,000 level.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Eff.org

The Next Patent Office Director Probably Shouldn't Be One Of The Guys Who Killed Patent Reform

Philip Johnson is Chief Intellectual Property Counsel of Johnson & Johnson, one of the largest pharmaceutical companies in the world.

Comment?

Related Topix: Patent / Trademark Law, Law, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Medical Device/Diagnostic Ind.

Top 10 U.S. Regions For Medical Devices Employment

The medical device sector has actually gained jobs between 2001 and 2012, and came out ahead in terms of growth in employment even taking into account the Great Recession and job losses in 2009 and 2010.

Comment?

Related Topix: Best of 2007, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Sun Jul 06, 2014

Hecklerspray

Chris Martin Is Giving Gwyneth A Meaty Middle Finger

Chris Martin had to give up a lot during his marriage to Gwyneth Paltrow . His dignity, warmth and affection, the ability to use normal products like Johnson&Johnson soap and tap water.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

The Jersey Journal

For Eden Autism Services CEO Peter Bell, autism advocacy is more than just a job

PLAINSBORO - Because more children these days get classified as autistic, and for other reasons experts do not yet fully understand, autism rates are soaring in New Jersey and elsewhere, but for Peter Bell, autism really hit the radar screen when his own son was diagnosed.

Comment?

Related Topix: Plainsboro, NJ, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Marketing, Middlesex County, NJ

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••